Paediatric Ophthalmology
Paediatric Cataract Surgery Update
Complex cases challenge surgeons. Clare Quigley MD reports from Milan.
Clare Quigley
Published: Wednesday, November 9, 2022
Attendees at the paediatric cataract session of the World Society of Paediatric Ophthalmology and Strabismus meeting held in conjunction with the annual ESCRS Congress heard a series of presentations on particularly challenging cases.
Roberto Caputo MD opened with a discussion of the complex problem of paediatric cataract in uveitis. His approach to cataract in these cases is tailored to each patient.
“I ask myself three questions: first of all, who is the patient I am going to treat?” Dr Caputo said. “When can I do the surgery? And how can I do this surgery?”
He highlighted that cataract in Juvenile Idiopathic Arthritis (JIA) is particularly challenging, with a high risk of complications.
“Can we really wait three months without relapses to do surgery?” The three-month wait is a widespread approach to judging the safe time to wait until cataract surgery in a patient with uveitis, but Dr Caputo questioned whether this is always the best approach, especially in a child with a dense cataract.
Marta Morales MD, a paediatric ophthalmologist in Barcelona, Spain, also discussed timing decisions—though in infant cataract surgery. “It is not recommended to implant an IOL before seven months of age,” she said. “This is [particularly] due to the risk of visual axis opacification and subsequent requirement for surgery.”
“If we have a dense congenital cataract, we should operate as soon as possible, but it is better not to operate before four weeks of age,” Dr Morales said. “During this age, the anterior segment is still developing.” Performing surgery at this neonatal development stage can increase the risk of glaucoma.
Hannah Scanga, genetic counsellor in UPMC Pittsburgh, Pennsylvania, US, talked about genetics of paediatric cataract. “Your highest diagnostic rate will be found with bilateral cataracts,” Ms Scanga said. Determining a genetic cause starts with history and exam, so she suggested examining the parents as well.
Important findings in parents can help narrow down the search for a causal mutation—for example, in mothers who are carriers of Lowe syndrome, spoke-like lens changes may be observed.
“Genetic causes continue to be identified,” Ms Scanga said. “Customisation is helpful.” She recommended a multigene panel as an effective investigative tool.
Göran Darius Hildebrand MD, Oxford, UK, reiterated paediatric cataract surgery is a vital treatment and that problems arise in postponing surgery. “Delayed surgery leads to permanent brain damage in the form of amblyopia, strabismus, and nystagmus.”
Dr Hildebrand said the best formulae available for use in children are SRKT and Holladay 1, as evidenced by a recent meta-analysis.i But even the best available formulae do not yield results comparable to the accuracy of biometry in adults.
“The [rate of] absolute prediction error outside two dioptres reaches 50%.” This error rate is due to numerous factors specific to children, including technical issues obtaining biometry and variable childhood emmetropization.
Dr Hildebrand went on to discuss different approaches to reduce visual axis opacification in children, highlighting the utility of the bag-in-the-lens (BIL), invented by Prof Marie-José Tassignon. For surgeons without access to BIL, optic capture of a sulcus IOL optic through the anterior and the posterior capsule is a potential method to reduce risk of opacification of the visual axis.
i Zhong et al. Journal of Refractive Surgery. 2021.
Roberto Caputo MD is Director, Department of Ophthalmology, A Meyer Children’s Hospital, Florence, Italy. r.caputo@meyer.it
Marta Morales Ballús MD, SJD Barcelona Children’s Hospital, Barcelona, Spain.
Hannah Scanga, genetic counsellor in UPMC Pittsburgh, Pennsylvania, US.
G Darius Hildebrand FRCS, FRCOphth, FEBO is Head of Paediatric Ophthalmology and Strabismus, Oxford Eye Hospital, UK. darius.hildebrand@ouh.nhs.uk
Tags: 40th Congress of the ESCRS, Paediatric
Latest Articles
A New High for Hyperopia
Hyperopia patients can expect a rise in the array of treatments.
Research Committee is Engine Driving the Future of ESCRS
Commitment to evidence-based medicine anchors studies and other projects.
ESCRS EPICAT Study Updates
Early results suggest subconjunctival 10 mg triamcinolone an effective strategy for dropless cataract surgery.
Second Global Consensus on Keratoconus
Forthcoming position paper to provide an updated and expanded view on evaluation and management.
Know Thy Enemy
Education for All Is What Makes ESCRS Unique
Surgeons Split on Post-Surgery Inflammation Control
Leading surgeons weigh whether or how to use a dropless regimen after cataract surgery.
Thinking of Selling Your Practice?
Planning an exit strategy is best begun early in your career.